A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP

Clinical trial NCT06362759 · COMPLETED

Trial details

NCT number: NCT06362759
Sponsor: Tourmaline Bio, Inc., a Novartis Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Diseases Chronic Kidney Insufficiency Chronic Renal Diseases Chronic Renal Insufficiency Kidney Insufficiency, Chronic C-Reactive Protein High Sensitivity C-Reactive Protein Hs-CRP hsCRP

Start date: 2024-05-15
Primary completion: 2025-03-06
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.